Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05744466
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
The purpose of this study is to understand the comparative effectiveness of deucravacitinib versus apremilast in adults with plaque psoriasis.
Official title: A Real-world, Prospective, Observational Study of the Comparative Effectiveness of Deucravacitinib Versus Apremilast in Adults With Plaque Psoriasis - North American Region
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1500
Start Date
2022-09-30
Completion Date
2027-12-10
Last Updated
2024-07-23
Healthy Volunteers
No
Conditions
Interventions
DRUG
Deucravacitinib
As prescribed by treating clinician
DRUG
Apremilast
As prescribed by treating clinician
Locations (1)
Local Institution
Waltham, Massachusetts, United States